The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort study

References

• Zain JM, Hanona P. Aggressive T-cell lymphomas: 2021 updates on diagnosis, risk stratification and management. Am J Hematol. 2021;96(8):1027–1046.
   PubMed Web of Science ®Google Scholar
• Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the international peripheral T-cell lymphoma project. Blood [Internet]. 2011;117(12):3402–3408.
   Web of Science ®Google Scholar
• Carson KR, Horwitz SM, Pinter-Brown LC, et al. A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer. 2017;123(7):1174–1183.
   PubMed Web of Science ®Google Scholar
• Idrobo H, Beltrán BE, M LV, et al. Serum albumin is an independent factor predicting survival in patients with peripheral T cell lymphoma: a Multi-Institutional study from the latin American working group for lymphomas (GELL). Blood. 2019;134(Supplement_1):4047–4047.
   Google Scholar
• Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103(7):2474–2479.
   PubMed Web of Science ®Google Scholar
• Vose JM, The International PTCL Project. International peripheral T-Cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood. 2005;106(11):811–811.
   Web of Science ®Google Scholar
• Piccaluga PP, Agostinelli C, Gazzola A, et al. Prognostic markers in peripheral T-cell lymphoma. Curr Hematol Malig Rep. 2010;5(4):222–228.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Wright G, Wang C, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014;123(19):2915–2923.
   PubMed Web of Science ®Google Scholar
• Armitage JO. The aggressive peripheral T-cell lymphomas: 2017. Am J Hematol. 2017;92(7):706–715.
   PubMed Web of Science ®Google Scholar
• Mu S, Ai L, Fan F, et al. Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis. Cancer Cell Int. 2018;18(1):119.
   PubMedGoogle Scholar
• Li Q, Gao S, Ma J, et al. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified. Leuk Res. 2018;73:5–11.
   PubMed Web of Science ®Google Scholar
• Beltran BE, Paredes S, Castro D, et al. High red cell distribution width is an adverse predictive and prognostic factor in patients with diffuse large B-Cell lymphoma treated with chemoimmunotherapy. Clin Lymphoma Myeloma Leuk. 2019;19(9):e551–e557.
   PubMed Web of Science ®Google Scholar
• Hohloch K, Ziepert M, Truemper L, et al. Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: results from prospective trials of the german high-grade non-hodgkin’s lymphoma study group. eJHaem. 2020;1(1):181–187.
   PubMedGoogle Scholar
• Zhang S, Li M, Yuan F, et al. The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma. Cancer Cell Int. 2019;19(1):272.
   PubMed Web of Science ®Google Scholar
• Beltran BE, Castro D, De La Cruz-Vargas JA, et al. The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma. Br J Haematol. 2019;184(4):650–653.
   PubMed Web of Science ®Google Scholar
• Luo H, Quan X, Song XY, et al. Red blood cell distribution width as a predictor of survival in nasal-type, extranodal natural killer/T-cell lymphoma. Oncotarget. 2017;8(54):92522–92535.
   PubMedGoogle Scholar
• Federico M, Bellei M, Marcheselli L, et al. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). a new prognostic model developed by the international T cell project network. Br J Haematol. 2018;181(6):760–769.
   PubMed Web of Science ®Google Scholar
• Wang Q X, Li S h, Ji B y, et al. Lymphocyte/monocyte ratio is a novel predictor for early stage extranodal natural killer/T-cell lymphoma, nasal type. J Cancer. 2017;8(6):1030–1037.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi Y, Shen H, et al. The prognostic value of platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in the treatment response and survival of patients with peripheral T-cell lymphoma. Leuk Lymphoma. 2020;61(3):623–630.
   PubMed Web of Science ®Google Scholar
• Beltran BE, Aguilar C, Quiñones P, et al. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016;57(1):58–62.
   PubMed Web of Science ®Google Scholar
• Obama K, Tabuchi T, Inoue H. Prognostic impact of red cell distribution width in adult T-cell leukemia/lymphoma. Leuk Res. 2020;99:106474.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
   PubMed Web of Science ®Google Scholar
• Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol. 1991;79(3):428–437.
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive Non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Ai L, Mu S, Hu Y. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis. Cancer Cell Int. 2018;18(1):18.
   PubMedGoogle Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the lugano classification. J Clin Oncol. 2014;32(27):3059–3068.
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27(3):453–459.
   PubMed Web of Science ®Google Scholar
• Periša V, Zibar L, Sinčić-Petričević J, et al. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study. Croat Med J. 2015;56(4):334–343.
   PubMed Web of Science ®Google Scholar
• Miao Y, Zhou XH, Guo JJ, et al. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Cancer Med. 2019;8(6):2751–2758.
   PubMed Web of Science ®Google Scholar
• Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;9:71–74.
   PubMedGoogle Scholar
• Agarwal S. Red cell distribution width, inflammatory markers and cardiorespiratory fitness: results from the national health and nutrition examination survey. Indian Heart J. 2012;64(4):380–387.
   PubMedGoogle Scholar
• Montagnana M, Danese E. Red cell distribution width and cancer. Ann Transl Med. 2016;4:399.
   PubMed Web of Science ®Google Scholar
• Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4):628–632.
   PubMed Web of Science ®Google Scholar
• Balkwill FR, Mantovani A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol. 2012;22(1):33–40.
   PubMed Web of Science ®Google Scholar
• Vose JM, Neumann M, Harris ME. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol. 2008;26:4124–4130.
   PubMed Web of Science ®Google Scholar
• Ellin F, Landström J, Jerkeman M, et al. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the swedish lymphoma registry. Blood. 2014;124(10):1570–1577.
   PubMed Web of Science ®Google Scholar